Citation: Zhang Xiao-Xiao, Ma Shuang-Cheng, Mao Peng, Wang Ya-Dan. A new bisbenzylisoquinoline alkaloid from Plumulanelumbinis[J]. Chinese Chemical Letters, ;2016, 27(12): 1755-1758. doi: 10.1016/j.cclet.2016.06.051 shu

A new bisbenzylisoquinoline alkaloid from Plumulanelumbinis

  • Corresponding author: Ma Shuang-Cheng, masc@nicpbp.org.cn
  • Received Date: 10 May 2016
    Revised Date: 17 June 2016
    Accepted Date: 27 June 2016
    Available Online: 16 December 2016

Figures(5)

  • One new bisbenzylisoquinoline alkaloid, neferine N-oxide (1), along with three known compounds, neferine (2), liensinine (3), and isoliensinine (4), were isolated from Plumulanelumbinis-the embryo of the seed of Nelumbonucifera. Their structures were elucidated by extensive spectroscopic analysis (MS, UV, IR, NMR), and the absolute configurations were determined by experimental circulardichroism (CD) spectra. Compound 1 is a new naturally occurring bisbenzylisoquinoline alkaloid with an N-oxide functionality, and the CD spectrum of (1R, 1'R) neferine is first reported. The antioxidant activities of compounds 1-4 were evaluated using the ORAC assay, which illustrated that all these compounds showed the different levels of oxygen radical absorbance capacity.
  • The rich structural diversity and complexity of molecules has always captured the attention of chemists to design cost-effective and sustainable synthetic ways [1], especially diversity-oriented synthesis of known natural and synthetic bioactive compounds [2]. In this context, spirocyclic benzofuranones have attracted considerable interest due to their privileged structural motifs found in natural and unnatural compounds with diverse and important biological activities (Fig. 1) [3]. There are some examples, concerning the catalytic asymmetric construction of such typically spirocyclic benzofuranones, have been disclosed [4, 5]. In spite of these elegant progresses, catalytic asymmetric methods for catalytic asymmetric assembly of spirocyclohexane-based benzofuranones have been less studied (Scheme 1a).

    Figure 1

    Figure 1.  Representative natural products and our target molecule.

    Scheme 1

    Scheme 1.  Design of chiral bispiro[benzofuran-oxindole/benzofuran-chromanone]s.

    Spirocyclic oxindoles [6] with carbocyclic six-membered rings are also important substructures that are widely present in numerous bioactive natural products (Fig. 1) [7]. Consequently, considerable effort has been devoted to asymmetric approaches to access enantioenriched spirocyclohexane oxindoles [7, 8]. However, highly efficient, diastereoselective, and enantioselective reactions generating complex and structurally diverse chiral spirocyclohexane oxindoles in one step remain a challenging but highly desirable goal in organic synthesis (Scheme 1a).

    Chromanones are an important class of heterocycles containing the core structure of dihydrobenzopyranone. Even though there exist many strategies for the asymmetric synthesis of chiral chromanones with only one chiral center [9], attempts toward the direct asymmetric synthesis of enantioenriched fused chromanone systems bearing two consecutive stereocenters are limited [10]. Especially, fused ring chromanone skeletons are also abundant in natural products like cyclopentene, cyclohexanone or cyclohexane fused chromanones (Fig. 1) [11]. The use of readily available chromones as a class of two-carbon building blocks to participate Michael cycloaddition reactions presents a promising one [12]. However the activation of the chemically inert chromones retards the development of this methold. Therefore, the stereoselective construction of fused ring chromanones is also a highly desirable but challenging goal.

    Considering the wide occurrence of chromanones, spirocyclohexanebenzofuranones and spirocyclohexaneoxindoles in natural products and drugs, integrating these medicinally relevant motifs to generate unprecedented polycyclic skeletons would be highly desirable [1, 2]. The intimating challenge lies in the scarcity of efficient pathways to rapidly install these structural units simultaneously. Herein, we hypothesized that highly functionalized chiral bispiro[benzofuran-oxindole/benzofuran-chromanone]s could be constructed via an organocatalytic domino inter-/intramolecular Michael cycloaddition of 3-substituted methylenebenzofuranone and bifunctional chromone-oxindole/benzofuran synthon. To the best of our knowledge, if successful, this is the first example of bifunctional chromone-benzofuranone synthon directed organocatalytic tandem reaction, and also the first example of the bispiro [benzofuran-oxindole]s and bispirobenzofuranone (Scheme 1b).

    Initially, the reaction of tert-butyl ester substituted methylenebenzofuranone 1a with chromone-oxindole synthon 2a [13] was investigated under the catalysis of quinine-derived squaramidetertiary amine C1 (Fig. 2) (Table 1, entry 1). Gratifyingly, the designed inter-/intramolecular Michael cycloaddition reaction indeed afforded the desired product 3a in a 78% yield albeit with 99% ee and >20:1 dr. This preliminary result demonstrated the feasibility of our design. In order to improve the yield, other chiral bifunctional tertiaryamine catalysts C2-C10 (Fig. 2) were utilized as catalysts in the reaction (entries 2–10). It was found that 10 mol% of quinine-derived thiourea-tertiary amine catalyst C2 fully converted chromone-oxindole synthon 1a into the desired product 3a with good control over the stereochemistry (90% yield, 99% ee, >20:1 dr) (entry 2). The subsequent evaluation of solvents discovered that Et2O could deliver the cycloaddition with better enantioselectivity than other solvents (entry 2 vs. entries 11–13). Thus, the optimal reaction conditions were chosen as those illustrated in entry 2.

    Figure 2

    Figure 2.  Structures of organocatalysts screened in this text.

    Table 1

    Table 1.  Optimization of reaction conditions for synthesis of compound 3a.a
    DownLoad: CSV

    After establishing the optimal reaction conditions, the substrate scope and limitations were explored. Initially, the possibility to employ various 3-substituted methylenebenzofuranones 1 was evaluated using chromone-oxindole synthon 2a as a model substrate (Scheme 2, products 3a-d). The reaction proved unbiased towards the substituents of substrates 1. Notably, in all of the cases high yields and high stereoselectivities were observed. Replacement of a tert-butyl ester substituent with an ethyl ester group in 2 was also well tolerated, could deliver the desired products 3 with excellent dr and ee (products 3b, 3d, 3f, 3h, 3j, 3m, 3o and 3q). Moreover, the reaction was shown to work well with benzoyl substituted substrates 1 to give the desired products 3t-w with very good yields (70%–85%), diastereoselectivities (all cases >20:1 dr), and good enantioselectivities (93%–98% ee).

    Scheme 2

    Scheme 2.  Substrate scope to compounds 3 and 5.

    Then, various chromone-oxindole synthons 2 were reacted with 3-substituted methylenebenzofuranones 1 (Scheme 2). To our delight, a highly efficient synthesis was observed under the reaction conditions in highly enantioselective fashions (products 3e-s with 96% to >99% ee). The reactions were shown to work well with a range of chromone-oxindole synthons 2 bearing either electronwithdrawing or electron-donating groups in the chromone ring to give the desired products 3e-k and 3s with very good yields (up to 93%), excellent diastereoselectivities (all cases >20:1 dr) and enantioselectivities (96% to >99% ee).

    Inspired by the success in the chromone-oxindole synthons 2, and based on diverse structural library design, considering that bispiro[bibenzofuran-chromanone]s 5 would be medicinally important hybrids for the development of new biological molecules, subsequently, we further designed and synthesized a novel bifunctional benzofuran-chromone 4 as a 4C synthon and was then subjected to methylene benzofuranone 1 in 3.0 mL of Et2O/DCM (1:1, v/v) at room temperature for 3 day. The reaction proceeded smoothly, affording the medicinally important bispiro [benzofuran-benzofuran-chromanone]s 5a in 68% yield with 98% ee, 92:8 dr. The reaction scope generally proved to be broad with respect to a wide variety of electron-rich and -poor reagents 1 and 4 to give diversely substituted bispiro[bibenzofuran-chromanone]s 5a-k in 58%–80% yields with 93% to >99% ee and up to >20:1 dr.

    The absolute configuration was unambiguously assigned on the basis of the X-ray analysis of the products 3a, 3c and 5a (Fig. 3). The absolute configurations of all remaining products 3 and 5 were given by analogy.

    Figure 3

    Figure 3.  The X-ray crystal structures of enantiopure 3a, 3c and 5a.

    Based on the experimental results, we suggested a possible bifunctional catalytic mode to account for the observed stereoselectivities (Scheme 3), The tertiary amine group of the catalyst C2 acted as a base to deprotonate the OH group of the enolized substrate 2 or 4. Meanwhile, the carbonyl group of substrate 1 was activated by catalyst C2 via forming a hydrogen bond. Subsequently, the Re-face of the 1 was preferably attacked by the Si-face of enolated substrate 2 or 4, delivering the transient Michael adduct intermediate under this dual activating mode of chiral catalyst C2. Finally, the α-position of the resulting prochiral nucleophile intermediate initiates an intermolecular annulation process through the attack to the Si-face of the electron-defficient chromone moiety to accomplish the desired (C1'S, C2'R, C4'S, C5'S, C6'S)-configured 3 or 5.

    Scheme 3

    Scheme 3.  A plausible reaction mechanism.

    Subsequently, we carried out two gram-scale inter-/intramolecular Michael cycloadditions to examine the applicability of the reaction. As shown in Scheme 4, the gram-scale reaction could smoothly take place to give products 3c and 5a with excellent enantio-and, diastereoselectivities, which was similar to the results of the small-scale reaction (for details, see the Supporting infomation).

    Scheme 4

    Scheme 4.  Scale-up reaction.

    In summary, we have demonstrated that a wide range of complex bispiro[benzofuran-oxindole/benzofuran-chromanone]s 3 and 5 can be efficiently assembled in high stereoselectivity in a single step from bifunctional chromone-oxindole/benzofuran synthons 2 and 4 servring as starting materials. The transformation provides products 3 and 5 comprised of five consecutive stereocenters including two spiro quaternary carton centers, in high yields and stereoselectivities (up to 93% yield, >20:1 dr and >99% ee). Moreover, this is the first example of the bifunctional chromonebenzofuranone synthon 4 directed organocatalytic tandem reaction, and also the first example of the bispiro[benzofuran-oxindole] and bispirobenzofuranone, potentially useful in medicinal chemistry. We believe this strategy would broaden the synthetic utility of bifunctional chromone synthon in the assembly of biologically valuable compounds.

    This work was received financial support from the National Nature Science Foundation of China (Nos. 81760625, 81660576 and 81560563) and Projects of Guizhou Province (Nos. [2016]5623, JG [2016]06, [2019]1402, [2017]5609 and [2018]5781).

    Supplementary material related to this article can befound, inthe online version, at doi: https://doi.org/10.1016/j.cclet.2019.06.015.


    1. [1]

      Pharmacopoeia Commission of China, Chinese Pharmacopoeia, 1, Chemical Industry Press, Beijing, 2015, pp. 273-274.

    2. [2]

      Z.T Lin, R.N Yang, Z Guan, A.L Chen, W Li. Ultra-performance LC separation and quadrupole time-of-flight MS identification of major alkaloidsin plumula nelumbinis[J]. Phytochem. Anal, 2014,25:485-494. doi: 10.1002/pca.v25.6

    3. [3]

      J Yang, K.L Zhou. NMR spectroscopic analysis of neferine and isoliensinine[J]. Magn. Reson. Chem, 2004,42:994-997. doi: 10.1002/(ISSN)1097-458X

    4. [4]

      A Itoh, T Saitoh, K Tani. Bisbenzylisoquinoline alkaloids from Nelumbonucifera[J]. Chem. Pharm. Bull, 2011,59:947-951. doi: 10.1248/cpb.59.947

    5. [5]

      S Nishibe, H Tsukamoto, H Kinoshita, S Kitagawa, A Sakushima. Alkaloids from embryo of the seed of Nelumbonucifera[J]. J. Nat. Prod, 1986,49:547-548.  

    6. [6]

      W.S Hu, L.J Guo, X.L Feng, M.X Jiang. Hypotensive effects of neferine[J]. Chin. J. Pharmacol. Toxicol, 1990,4:107-110.  

    7. [7]

      M Zhang, L Chen. Berberine in type 2 diabetes therapy:a new perspective for an old antidiarrheal drug?[J]. Acta Pharm. Sinica, 2012,B2:379-386.  

    8. [8]

      Z.T Lin, H Wang, Q.R Fu. Simultaneous separation, identification and activity evaluation of three butyrylcholinesterase inhibitors from Plumula nelumbinis using on-line HPLC-UV coupled with ESI-IT-TOF-MS and BChE biochemical detection[J]. Talanta, 2013,110:180-189. doi: 10.1016/j.talanta.2013.02.033

    9. [9]

      J.H Xiao, J.H Zhang, H.L Chen, X.L Feng, J.L Wang. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice[J]. Planta Med, 2005,71:225-230. doi: 10.1055/s-2005-837821

    10. [10]

      Y Kashiwada, A Aoshima, Y Ikeshiro. Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbonucifera, and structure-activity correlations with related alkaloids[J]. Bioorg. Med. Chem, 2005,13:443-448. doi: 10.1016/j.bmc.2004.10.020

    11. [11]

      J.H Xiao, Y.L Zhang, L.L Ding, X.L Feng, J.L Wang. Effects of isoliensinine on proliferation of porcine coronary arterial smooth muscle cells induced by phenylephrine[J]. Acta Pharm. Sinica, 2005,40:105-110.  

    12. [12]

      G.Z Ye, J.H Wang, A.X Sun. Poteintation of vincristine-induced apoptosis by tetrandrine, neferine and dauricine in the human mammary MCF-7 multidrugresistant cells[J]. Acta Pharm. Sinica, 2001,36:96-99.

    13. [13]

      K Nishimura, S Horii, T Tanahashi, Y Sugimoto, J Yamada. Synthesis and pharmacological activity of alkaloids from embryo of Lotus, Nelumbonucifera[J]. Chem. Pharm. Bull, 2013,61:59-68. doi: 10.1248/cpb.c12-00820

    14. [14]

      J.Z Wu, H.L Yuan, J.L Wang, H.D Sun. Spectroscopic elucidation of liensinine[J]. Chin. Tradit. Herbal Drugs, 1998,29:364-367.

    15. [15]

      Z.Q Zhou, H.X Fan, R.R He. Lycibarbarspermidines A-O, new dicaffeoylspermidine derivatives from wolfberry, with activities against Alzheimer's disease and oxidation[J]. J. Agric. Food Chem, 2016,64:2223-2237. doi: 10.1021/acs.jafc.5b05274

    16. [16]

      P.L Ding, H Huang, P Zhou, D.F Chen. Quinolizidine alkaloids with anti-HBV activity from Sophoratonkinensis[J]. Planta Med, 2006,72:854-856. doi: 10.1055/s-2006-946639

    1. [1]

      Pharmacopoeia Commission of China, Chinese Pharmacopoeia, 1, Chemical Industry Press, Beijing, 2015, pp. 273-274.

    2. [2]

      Z.T Lin, R.N Yang, Z Guan, A.L Chen, W Li. Ultra-performance LC separation and quadrupole time-of-flight MS identification of major alkaloidsin plumula nelumbinis[J]. Phytochem. Anal, 2014,25:485-494. doi: 10.1002/pca.v25.6

    3. [3]

      J Yang, K.L Zhou. NMR spectroscopic analysis of neferine and isoliensinine[J]. Magn. Reson. Chem, 2004,42:994-997. doi: 10.1002/(ISSN)1097-458X

    4. [4]

      A Itoh, T Saitoh, K Tani. Bisbenzylisoquinoline alkaloids from Nelumbonucifera[J]. Chem. Pharm. Bull, 2011,59:947-951. doi: 10.1248/cpb.59.947

    5. [5]

      S Nishibe, H Tsukamoto, H Kinoshita, S Kitagawa, A Sakushima. Alkaloids from embryo of the seed of Nelumbonucifera[J]. J. Nat. Prod, 1986,49:547-548.  

    6. [6]

      W.S Hu, L.J Guo, X.L Feng, M.X Jiang. Hypotensive effects of neferine[J]. Chin. J. Pharmacol. Toxicol, 1990,4:107-110.  

    7. [7]

      M Zhang, L Chen. Berberine in type 2 diabetes therapy:a new perspective for an old antidiarrheal drug?[J]. Acta Pharm. Sinica, 2012,B2:379-386.  

    8. [8]

      Z.T Lin, H Wang, Q.R Fu. Simultaneous separation, identification and activity evaluation of three butyrylcholinesterase inhibitors from Plumula nelumbinis using on-line HPLC-UV coupled with ESI-IT-TOF-MS and BChE biochemical detection[J]. Talanta, 2013,110:180-189. doi: 10.1016/j.talanta.2013.02.033

    9. [9]

      J.H Xiao, J.H Zhang, H.L Chen, X.L Feng, J.L Wang. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice[J]. Planta Med, 2005,71:225-230. doi: 10.1055/s-2005-837821

    10. [10]

      Y Kashiwada, A Aoshima, Y Ikeshiro. Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbonucifera, and structure-activity correlations with related alkaloids[J]. Bioorg. Med. Chem, 2005,13:443-448. doi: 10.1016/j.bmc.2004.10.020

    11. [11]

      J.H Xiao, Y.L Zhang, L.L Ding, X.L Feng, J.L Wang. Effects of isoliensinine on proliferation of porcine coronary arterial smooth muscle cells induced by phenylephrine[J]. Acta Pharm. Sinica, 2005,40:105-110.  

    12. [12]

      G.Z Ye, J.H Wang, A.X Sun. Poteintation of vincristine-induced apoptosis by tetrandrine, neferine and dauricine in the human mammary MCF-7 multidrugresistant cells[J]. Acta Pharm. Sinica, 2001,36:96-99.

    13. [13]

      K Nishimura, S Horii, T Tanahashi, Y Sugimoto, J Yamada. Synthesis and pharmacological activity of alkaloids from embryo of Lotus, Nelumbonucifera[J]. Chem. Pharm. Bull, 2013,61:59-68. doi: 10.1248/cpb.c12-00820

    14. [14]

      J.Z Wu, H.L Yuan, J.L Wang, H.D Sun. Spectroscopic elucidation of liensinine[J]. Chin. Tradit. Herbal Drugs, 1998,29:364-367.

    15. [15]

      Z.Q Zhou, H.X Fan, R.R He. Lycibarbarspermidines A-O, new dicaffeoylspermidine derivatives from wolfberry, with activities against Alzheimer's disease and oxidation[J]. J. Agric. Food Chem, 2016,64:2223-2237. doi: 10.1021/acs.jafc.5b05274

    16. [16]

      P.L Ding, H Huang, P Zhou, D.F Chen. Quinolizidine alkaloids with anti-HBV activity from Sophoratonkinensis[J]. Planta Med, 2006,72:854-856. doi: 10.1055/s-2006-946639

  • 加载中
    1. [1]

      Xinyi Hu Riguang Zhang Zhao Jiang . Depositing the PtNi nanoparticles on niobium oxide to enhance the activity and CO-tolerance for alkaline methanol electrooxidation. Chinese Journal of Structural Chemistry, 2023, 42(11): 100157-100157. doi: 10.1016/j.cjsc.2023.100157

    2. [2]

      Li LiXue KeShan WangZhuo JiangYuzheng GuoChunguang Kuai . Antioxidative strategies of 2D MXenes in aqueous energy storage system. Chinese Chemical Letters, 2025, 36(5): 110423-. doi: 10.1016/j.cclet.2024.110423

    3. [3]

      Jingping HuJing Xu . Total synthesis of a putative yuzurimine-type Daphniphyllum alkaloid C14epi-deoxycalyciphylline H. Chinese Chemical Letters, 2024, 35(4): 108733-. doi: 10.1016/j.cclet.2023.108733

    4. [4]

      Jian SongShenghui WangQiuge LiuXiao WangShuo YuanHongmin LiuSaiyang ZhangN-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations. Chinese Chemical Letters, 2025, 36(2): 109678-. doi: 10.1016/j.cclet.2024.109678

    5. [5]

      Huan YaoJian QinYan-Fang WangSong-Meng WangLiu-Huan YiShi-Yao LiFangfang DuLiu-Pan YangLi-Li Wang . Ultra-highly selective recognition of nucleosides over nucleotides by rational modification of tetralactam macrocycle and its application in enzyme assay. Chinese Chemical Letters, 2024, 35(6): 109154-. doi: 10.1016/j.cclet.2023.109154

    6. [6]

      Chunyu YanQinglong QiaoWei ZhouXuelian ZhouYonghui ChenLu MiaoZhaochao Xu . FRET-based in vitro assay for rapid detecting of SARS-CoV-2 entry inhibitors. Chinese Chemical Letters, 2025, 36(5): 110258-. doi: 10.1016/j.cclet.2024.110258

    7. [7]

      Ruiying Liu Li Zhao Baishan Liu Jiayuan Yu Yujie Wang Wanqiang Yu Di Xin Chaoqiong Fang Xuchuan Jiang Riming Hu Hong Liu Weijia Zhou . Modulating pollutant adsorption and peroxymonosulfate activation sites on Co3O4@N,O doped-carbon shell for boosting catalytic degradation activity. Chinese Journal of Structural Chemistry, 2024, 43(8): 100332-100332. doi: 10.1016/j.cjsc.2024.100332

    8. [8]

      Ran ZhuPan ZhangYitong XuJiutong MaQiong Jia . Design of host-guest interaction based molecularly imprinted polymers: Targeting recognition of the epitope of neuron-specific enolase via a SERS assay. Chinese Chemical Letters, 2025, 36(6): 110259-. doi: 10.1016/j.cclet.2024.110259

    9. [9]

      Lijun YanShiqi ChenPenglu WangXiangyu LiuLupeng HanTingting YanYuejin LiDengsong Zhang . Hydrothermally stable metal oxide-zeolite composite catalysts for low-temperature NOx reduction with improved N2 selectivity. Chinese Chemical Letters, 2024, 35(6): 109132-. doi: 10.1016/j.cclet.2023.109132

    10. [10]

      Shanyuan BiJin ZhangDengchao PengDanhong ChengJianping ZhangLupeng HanDengsong Zhang . Improved N2 selectivity for low-temperature NOx reduction over etched ZSM-5 supported MnCe oxide catalysts. Chinese Chemical Letters, 2025, 36(5): 110295-. doi: 10.1016/j.cclet.2024.110295

    11. [11]

      Guangyao WangZhitong XuYe QiYueguang FangGuiling NingJunwei Ye . Electrospun nanofibrous membranes with antimicrobial activity for air filtration. Chinese Chemical Letters, 2024, 35(10): 109503-. doi: 10.1016/j.cclet.2024.109503

    12. [12]

      Ting WangXin YuYaqiang Xie . Unlocking stability: Preserving activity of biomimetic catalysts with covalent organic framework cladding. Chinese Chemical Letters, 2024, 35(6): 109320-. doi: 10.1016/j.cclet.2023.109320

    13. [13]

      Fangping YangJin ShiYuansong WeiQing GaoJingrui ShenLichen YinHaoyu Tang . Mixed-charge glycopolypeptides as antibacterial coatings with long-term activity. Chinese Chemical Letters, 2025, 36(2): 109746-. doi: 10.1016/j.cclet.2024.109746

    14. [14]

      Chong LiuLing LiJiahui GaoYanwei LiNazhen ZhangJing ZangCong LiuZhaopei GuoYanhui LiHuayu Tian . The study of antibacterial activity of cationic poly(β-amino ester) regulating by amphiphilic balance. Chinese Chemical Letters, 2025, 36(2): 110118-. doi: 10.1016/j.cclet.2024.110118

    15. [15]

      Di ZHANGTianxiang XIEXu HEWanyu WEIQi FANJie QIAOGang JINNingbo LI . Construction and antitumor activity of pH/GSH dual-responsive magnetic nanodrug. Chinese Journal of Inorganic Chemistry, 2025, 41(4): 786-796. doi: 10.11862/CJIC.20240329

    16. [16]

      Xiangyuan Zhao Jinjin Wang Jinzhao Kang Xiaomei Wang Hong Yu Cheng-Feng Du . Ni nanoparticles anchoring on vacuum treated Mo2TiC2Tx MXene for enhanced hydrogen evolution activity. Chinese Journal of Structural Chemistry, 2023, 42(10): 100159-100159. doi: 10.1016/j.cjsc.2023.100159

    17. [17]

      Anqiu LIULong LINDezhi ZHANGJunyu LEIKefeng WANGWei ZHANGJunpeng ZHUANGHaijun HAO . Synthesis, structures, and catalytic activity of aluminum and zinc complexes chelated by 2-((2,6-dimethylphenyl)amino)ethanolate. Chinese Journal of Inorganic Chemistry, 2024, 40(4): 791-798. doi: 10.11862/CJIC.20230424

    18. [18]

      Bin DongNing YuQiu-Yue WangJing-Ke RenXin-Yu ZhangZhi-Jie ZhangRuo-Yao FanDa-Peng LiuYong-Ming Chai . Double active sites promoting hydrogen evolution activity and stability of CoRuOH/Co2P by rapid hydrolysis. Chinese Chemical Letters, 2024, 35(7): 109221-. doi: 10.1016/j.cclet.2023.109221

    19. [19]

      Tao YuVadim A. SoloshonokZhekai XiaoHong LiuJiang Wang . Probing the dynamic thermodynamic resolution and biological activity of Cu(Ⅱ) and Pd(Ⅱ) complexes with Schiff base ligand derived from proline. Chinese Chemical Letters, 2024, 35(4): 108901-. doi: 10.1016/j.cclet.2023.108901

    20. [20]

      Jia ChenYun LiuZerong LongYan LiHongdeng Qiu . Colorimetric detection of α-glucosidase activity using Ni-CeO2 nanorods and its application to potential natural inhibitor screening. Chinese Chemical Letters, 2024, 35(9): 109463-. doi: 10.1016/j.cclet.2023.109463

Metrics
  • PDF Downloads(1)
  • Abstract views(1198)
  • HTML views(30)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Address:Zhongguancun North First Street 2,100190 Beijing, PR China Tel: +86-010-82449177-888
Powered By info@rhhz.net

/

DownLoad:  Full-Size Img  PowerPoint
Return